Lifesci Capital Upgrades Ventyx Biosciences to Outperform From Market Perform, $5 Price Target
Lifesci Capital Upgrades Ventyx Biosciences to Outperform From Market Perform, $5 Price Target
Lifesci Capital将Ventyx Biosciences从市场表现上调至跑赢大盘，目标股价为5美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册